Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Astellas Pharma Inc. (4503)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,505.0 +51.0    +3.51%
26/04 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3942400007 
  • Volume: 11,281,100
  • Bid/Ask: 1,503.0 / 1,506.5
  • Day's Range: 1,446.0 - 1,505.0
Astellas Pharma Inc. 1,505.0 +51.0 +3.51%

4503 Balance Sheet

 
Featured here, the Balance Sheet for Astellas Pharma Inc., which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 1194730 1050102 1116756 1317454
Cash and Short Term Investments 335687 285436 363649 602813
Cash - - - -
Cash & Equivalents 335687 253978 333993 561487
Short Term Investments - 31458 29656 41326
Total Receivables, Net 548036 505905 504603 477214
Accounts Receivables - Trade, Net 534985 495961 487893 462503
Total Inventory 248738 225980 213648 200224
Prepaid Expenses - - - -
Other Current Assets, Total 62269 32781 34856 37203
Total Assets 3569603 3368682 3543021 2797958
Property/Plant/Equipment, Total - Net 293742 289029 296555 290784
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 418694 387969 403822 355683
Intangibles, Net 1453824 1452341 1532551 590424
Long Term Investments 15684 146620 149052 142972
Note Receivable - Long Term 13051 9944 16710 14711
Other Long Term Assets, Total 127292 - 1 1
Other Assets, Total -171392 -173065 -182159 -97821
Total Current Liabilities 1285725 1153715 1162259 991494
Accounts Payable 185193 150426 147250 138439
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 420400 407177 416558 309000
Current Port. of LT Debt/Capital Leases 51878 - 416558 309000
Other Current liabilities, Total 628254 596112 598451 544055
Total Liabilities 1973615 1865427 1903676 1219541
Total Long Term Debt 447738 465954 475353 52368
Long Term Debt 447738 465954 475353 52368
Capital Lease Obligations - - - -
Deferred Income Tax 51346 70013 92673 6539
Minority Interest - - - -
Other Liabilities, Total -231594 -495413 -243167 -139860
Total Equity 1595988 1503255 1639345 1578417
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 103001 103001 103001 103001
Additional Paid-In Capital 184070 182983 182148 180640
Retained Earnings (Accumulated Deficit) 809400 838621 884514 884534
Treasury Stock - Common -33783 -34147 -34417 -34476
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 533300 412797 504099 444718
Total Liabilities & Shareholders' Equity 3569603 3368682 3543021 2797958
Total Common Shares Outstanding 1793.07 1792.99 1792.86 1792.84
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4503 Comments

Write your thoughts about Astellas Pharma Inc.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Kambiz Salari
Kambiz Salari Dec 19, 2019 1:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It time to buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email